BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37458923)

  • 1. Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors.
    Paredes-Ruiz KJ; Chavira-Ramos K; Galvan-Arzate S; Rangel-López E; Karasu Ç; Túnez I; Skalny AV; Ke T; Aschner M; Orozco-Morales M; Colín-González AL; Santamaría A
    Neurotox Res; 2023 Dec; 41(6):514-525. PubMed ID: 37458923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.
    Kerr DM; Harhen B; Okine BN; Egan LJ; Finn DP; Roche M
    Br J Pharmacol; 2013 Jun; 169(4):808-19. PubMed ID: 23043675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice.
    Costola-de-Souza C; Ribeiro A; Ferraz-de-Paula V; Calefi AS; Aloia TP; Gimenes-Júnior JA; de Almeida VI; Pinheiro ML; Palermo-Neto J
    PLoS One; 2013; 8(10):e77706. PubMed ID: 24204926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoacylglycerol lipase inhibitor JZL184 prevents HIV-1 gp120-induced synapse loss by altering endocannabinoid signaling.
    Zhang X; Thayer SA
    Neuropharmacology; 2018 Jan; 128():269-281. PubMed ID: 29061509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
    Guindon J; Guijarro A; Piomelli D; Hohmann AG
    Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation.
    Bouchet CA; McPherson KB; Coutens B; Janowsky A; Ingram SL
    J Neurosci; 2023 Jul; 43(30):5458-5467. PubMed ID: 37414560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleamide Reduces Mitochondrial Dysfunction and Toxicity in Rat Cortical Slices Through the Combined Action of Cannabinoid Receptors Activation and Induction of Antioxidant Activity.
    Reyes-Soto CY; Villaseca-Flores M; Ovalle-Noguez EA; Nava-Osorio J; Galván-Arzate S; Rangel-López E; Maya-López M; Retana-Márquez S; Túnez I; Tinkov AA; Ke T; Aschner M; Santamaría A
    Neurotox Res; 2022 Dec; 40(6):2167-2178. PubMed ID: 36069981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice.
    von Rüden EL; Bogdanovic RM; Wotjak CT; Potschka H
    Neurobiol Dis; 2015 May; 77():238-45. PubMed ID: 25796567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cannabinoid Receptor-Mediated Mechanism Participates in the Neuroprotective Effects of Oleamide Against Excitotoxic Damage in Rat Brain Synaptosomes and Cortical Slices.
    Maya-López M; Rubio-López LC; Rodríguez-Alvarez IV; Orduño-Piceno J; Flores-Valdivia Y; Colonnello A; Rangel-López E; Túnez I; Prospéro-García O; Santamaría A
    Neurotox Res; 2020 Jan; 37(1):126-135. PubMed ID: 31286434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.
    Pan B; Wang W; Long JZ; Sun D; Hillard CJ; Cravatt BF; Liu QS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):591-7. PubMed ID: 19666749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
    Kinsey SG; Wise LE; Ramesh D; Abdullah R; Selley DE; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2013 Jun; 345(3):492-501. PubMed ID: 23412396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model.
    Wang J; Zhang X; Yang C; Zhao S
    Biochem Biophys Res Commun; 2020 May; 525(4):962-967. PubMed ID: 32173532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo.
    Bernal-Chico A; Canedo M; Manterola A; Victoria Sánchez-Gómez M; Pérez-Samartín A; Rodríguez-Puertas R; Matute C; Mato S
    Glia; 2015 Jan; 63(1):163-76. PubMed ID: 25130621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Effect of JZL184 in MPP(+)-Treated SH-SY5Y Cells Through CB2 Receptors.
    Aymerich MS; Rojo-Bustamante E; Molina C; Celorrio M; Sánchez-Arias JA; Franco R
    Mol Neurobiol; 2016 May; 53(4):2312-9. PubMed ID: 25976369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat.
    Woodhams SG; Wong A; Barrett DA; Bennett AJ; Chapman V; Alexander SP
    Br J Pharmacol; 2012 Dec; 167(8):1609-19. PubMed ID: 22924700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.
    Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Benyó Z; Offermanns S; Ruisanchez É; Szabó E; Takáts Z; Bátkai S; Tóth ZE; Hunyady L
    Mol Cell Endocrinol; 2015 Mar; 403():46-56. PubMed ID: 25595485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.
    Sciolino NR; Zhou W; Hohmann AG
    Pharmacol Res; 2011 Sep; 64(3):226-34. PubMed ID: 21600985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
    Cao Z; Mulvihill MM; Mukhopadhyay P; Xu H; Erdélyi K; Hao E; Holovac E; Haskó G; Cravatt BF; Nomura DK; Pacher P
    Gastroenterology; 2013 Apr; 144(4):808-817.e15. PubMed ID: 23295443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.